Image for Upcoming Webinar: Navigating New TGA Advertising Rules

Upcoming Webinar: Navigating New TGA Advertising Rules

March 27, 2024

Following our previous report the TGA has scheduled a webinar for all those who are interested in presenting their questions and participating in this update on the 10th of April. They promise to provide an update on any changes and to provide further clarity on the new regulations.

As an industry body APAN is pursuing a coalition with four other industry societies as regardless of the outcome, we still believe that collectively we can present our concerns cohesively and compellingly to the TGA.

We are convinced that there are several considerations that we wish to present that will provide them with a better understanding of how these new rules will impact both the industry and the public.

We will be discussing this at our conference in May and will discuss the regulations including ways to market your business with the new restrictions. Check out the lecture

Meanwhile, If you wish to attend the TGA meeting here are the details:

Topic: Advertising cosmetic injection health services compliant with therapeutic goods legislation.

In this webinar, you will learn about the TGA’s revised guidance on advertising health services that involve cosmetic injectables.

Most cosmetic injectables contain prescription-only substances which cannot be advertised to the public either directly or indirectly. Prescription-only medicines are high-risk, and patients should be assessed by a health professional before their use. Any reference to a prescription-only product or class of prescription-only products in advertising a health service is likely to be unlawful. The updated guidance brings consistency across many industries and with other international regulators.


Historically, the TGA has allowed indirect references to prescription medicines to be referenced in advertisements related to cosmetic health services. This was allowed only in the context of promoting the service and only by using generic non-product specific terms such as ‘wrinkle-reducing injections.’

When advertising health services where the available treatment(s) involve the use of prescription-only medicines or goods containing such substances, including clinics offering dermal fillers, advertisers should only refer to the type of consultations the service offers. For example: ‘Our clinic can provide consultations about reducing wrinkles.’


Alex Stevenson, Acting Assistant Director, Advertising and Compliance Education and Policy Section, TGA

Webinar details

Date: Wednesday, 10 April 2024

Time: 7:00 – 8:00 pm AEST

Where: online (Webex)

Advertising cosmetic injection health services compliant with therapeutic goods legislation | Therapeutic Goods Administration (TGA)

You may also like

Experience the Excitement at the Thriving Aesthetics Summit Workshops!

9 April 2024

Discover the enchanting skin wonders of exotic Black Seed Oil

9 April 2024

Fostering loyalty and retention strategies for Aestheticians amidst challenges

9 April 2024

The Latest Breakthroughs in Vitamin C for Skincare and Anti-Ageing

8 April 2024

Calling All Clinics, Injectors, and Aestheticians: Elevate Your Practice at Thriving Aesthetic Summit.

28 March 2024

Exploring the Differences: Laser vs. IPL for Hair Reduction and Skin Rejuvenation

27 March 2024

Let us serve you.
Become a member today!

Get started